loader image
Thursday, January 8, 2026
72.2 F
McAllen
- Advertisement -

Driscoll pharmacist appointed Congressional Captain

Community NewsPublisher's Picks
218

Translate to Spanish or other 102 languages!

Jennifer Witte, PharmD is shown here with Congressman Michael Cloud, U.S. Representative for the 27th District of Texas

Mega Doctor News

- Advertisement -

Jennifer Witte, PharmD, a dedicated cystic fibrosis clinical pharmacist for the Driscoll Children’s Hospital Cystic Fibrosis Center who is certified by the Society of Infectious Diseases Pharmacists (SIDP) in antimicrobial stewardship, was recently appointed the Congressional Captain for TX-27 by the Cystic Fibrosis Foundation CF Advocacy Department. She is shown here with Congressman Michael Cloud, U.S. Representative for the 27th District of Texas. They met to discuss cystic fibrosis and the PASTEUR Act, which is a bill introduced to the House and Senate that aims to improve antimicrobial stewardship and the development of antibiotics.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Dr. Hochman Funds Twentieth Annual Education Grant
Next article
Drugs used by some Type 2 diabetics may lessen their risk for severe COVID-19 complications

More Articles

Historic Reset of U.S. Nutrition Policy with New Food Pyramid

Mega Doctor News WASHINGTON, D.C. – U.S. Department of Health and Human Services...

Metabolic Trigger Identified That Shuts Down Key Tumor‑Fighting Gene

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center. 

No-Cost COVID-19 Testing Ends January 31st

The Hidalgo County Health & Human Services Department announces that no-cost COVID-19 testing at the Hidalgo County Public Health Laboratory will conclude on January 31, 2026.

MD Anderson Partners with SOPHiA GENETICS to Accelerate Innovation in AI Precision Oncology

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×